Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed-Start Analysis of the MOXIe Extension.

David R LynchMelanie P ChinSylvia BoeschMartin B DelatyckiPaola GiuntiAngie GoldsberryJ Chad HoyleCaterina MariottiKatherine D MathewsWolfgang NachbauerMegan O'GradySusan PerlmanS H SubramonyGeorge WilmotTheresa ZesiewiczColin J Meyer

Published in: Movement disorders : official journal of the Movement Disorder Society (2022)

These results support the positive results of MOXIe part 2 and indicate a persistent benefit of omaveloxolone treatment on disease course in Friedreich's ataxia. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keyphrases

early onset
randomized controlled trial
replacement therapy